Page last updated: 2024-11-02

phenylbutazone and Lupus Erythematosus, Chronic Cutaneous

phenylbutazone has been researched along with Lupus Erythematosus, Chronic Cutaneous in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maintz, J1
Henningsen, B1
Buchholz, K1
Harders, H1

Other Studies

1 other study available for phenylbutazone and Lupus Erythematosus, Chronic Cutaneous

ArticleYear
[Unusual clinical forms of pseudo-LE syndrome: an induced immune-complex disease? (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Jul-25, Volume: 100, Issue:30

    Topics: Adult; Aged; Antibodies; Bone Marrow Diseases; Female; Humans; Immune Complex Diseases; Lupus Erythe

1975